SHMSF yields 3478.26% · JNJ yields 2.13%● Live data
📍 SHMSF pulled ahead of the other in Year 1
Combined, SHMSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHMSF + JNJ for your $10,000?
Shimao Services Holdings Limited, an investment holding company, provides property management and community living services in the People's Republic of China. It operates in two segments, Property Management and Related Services; and City Services. The company offers property management services, including security, cleaning, greening and gardening, repair, and maintenance services to construction, gardening, and other property management companies. It also provides community value added services, such as community asset management, carpark asset operation, campus value-added, and retail services; sells hardware devices and software products; and home decoration services, including supply chain services of decoration materials, and marketing and promotion services to property owners and developers, technology companies, and other property management companies. In addition, the company offers value-added services, which comprise display units and property sales venue management, preliminary planning and design consultancy, and repair and maintenance management services to property developers; and city services that include sanitation, cleaning, and sewage and waste treatment. Further, it is involved in the real estate agency, wholesale and retail trading, construction decoration and other construction, education, enterprises management consulting, household management, engineering construction, and hotel management businesses. The company was founded in 2005 and is headquartered in Shanghai, the People's Republic of China. Shimao Services Holdings Limited is a subsidiary of Best Cosmos Limited.
Full SHMSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.